The potential of radioimmunotherapy as a new hope for HIV patients

Expert Review of Clinical Immunology

Volumn 10, Issue 5, 2014, Pages 553-555

  Tsukrov, Dina ^a   Dadachova, Ekaterina ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

ART; eradication; HIV; latency; radioimmunotherapy; reservoirs

Indexed keywords

ANTIRETROVIRUS AGENT; BISMUTH 213; GLYCOPROTEIN GP 41; MONOCLONAL ANTIBODY 2556; MONOCLONAL ANTIBODY 2556 BI 213; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANTIVIRAL RESISTANCE; CD4+ T LYMPHOCYTE; DISEASE CARRIER; DISEASE ERADICATION; DRUG MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOTOPE LABELING; LIFESPAN; NONHUMAN; PERSISTENT VIRUS INFECTION; RADIOIMMUNOTHERAPY; REVIEW; TREATMENT OUTCOME; VIRUS REPLICATION; ANIMAL; HIV INFECTIONS; MOUSE; MULTIMODALITY CANCER THERAPY; PROCEDURES; REPRODUCIBILITY;

ANIMALS; ANTI-RETROVIRAL AGENTS; COMBINED MODALITY THERAPY; HIV INFECTIONS; HUMANS; MICE; RADIOIMMUNOTHERAPY; REPRODUCIBILITY OF RESULTS;

EID: 84898904758     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2014.908706     Document Type: Review

References (18)

1. Katlama C, Deeks SG, Autran B, et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet 2013;381:2109-17
2. Saksena NK, Wang B, Zhou L, et al. HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites. HIV AIDS (Auckl) 2010;2: 103-22
3. Rao KS, Ghorpade A, Labhasetwar V. Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv 2009;6:771-84
4. Spudich S, Gonzalez-Scarano F. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb Perspect Med 2012;2:a007120
5. Archin NM, Vaidya NK, Kuruc JD, et al. Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci USA 2012;109:9523-8
6. Henrich T. Challenges and strategies towards functional cure: how low do you need to go? 6th International Workshop on HIV Persistence during Therapy; Miami, FL;2013
7. Eyal N, Kuritzkes DR. Challenges in clinical trial design for HIV-1 cure research. Lancet 2013;382:1464-5
8. Denton PW, Long JM, Wietgrefe SW, et al. Targeted cytotoxic therapy kills persisting HIV infected cells during ART. PLoS Pathog 2014;10:e1003872
9. Berger EA, Pastan I. Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs. PLoS Pathog 2010;6(6):e1000803
10. Dadachova E, Patel MC, Toussi S, et al. Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med 2006;3:e427
11. Bryan RA, Guimaraes AJ, Hopcraft S, et al. Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens. Mycopathologia 2012;173:463-71
12. Rivera J, Morgenstern A, Bruchertseifer F, et al. Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores. Antimicrob Agents Chemother 2014;58(3):1813-15
13. Dadachova E, Casadevall A. Radioimmunotherapy of infectious diseases. Semin Nucl Med 2009;39:146-53
14. Hutter G, Zaia JA. Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. Clin Exp Immunol 2011;163:284-95
15. Dadachova E, Kitchen SG, Bristol G, et al. Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication. PLoS ONE 2012;7: e31866
16. Tsukrov D MA, Kitchen SG, Gorny MK, et al. Targeting HIV with radioimmunotherapy and antiretroviral drugs. Clinical and Translational Science Award Symposium; Bronx, NY; 2013
17. McFarren A TD, Eugenin E, Morgenstern A, et al. A radiolabeled monoclonal antibody to gp41 eliminates HIV-1 infected monocytes after passing through a blood brain barrier model. 20th Conference on Retroviruses and Opportunistic Infections; Atlanta, GA; 2013
18. Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol 2012;30(14):1663-9